Schematic model of how the new drug, D4, inhibits hemichannels and alleviates neuroinflammation and seizure symptoms. The new drug, D4, is a selective blocker of connexin hemichannels. Excessive ...
This time it was announced on March 3 "WILLCOM develops high performance, low power consumption mobile terminal equipped with Windows VistaAbout the release date, specifications and exterior, etc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results